Sentences with phrase «breast cancer research using»

Channel 7 News about the QUT led breast cancer research using 3D printing technology for tissue engineering.

Not exact matches

«George Amedore has always been a leader, whether it's fighting for breast cancer research, using his own time and money to help rebuild the local Ronald McDonald House for sick children, or helping victims of Hurricane Irene, George Amedore fights for us.

Statement from Breast Cancer Care on research from the Queen's Medical Centre, Nottingham, presented to the seventh European Breast Cancer Conference on the use of beta - blockers to help reduce metastasis and improve survival in breast cancer patBreast Cancer Care on research from the Queen's Medical Centre, Nottingham, presented to the seventh European Breast Cancer Conference on the use of beta - blockers to help reduce metastasis and improve survival in breast cancer patCancer Care on research from the Queen's Medical Centre, Nottingham, presented to the seventh European Breast Cancer Conference on the use of beta - blockers to help reduce metastasis and improve survival in breast cancer patBreast Cancer Conference on the use of beta - blockers to help reduce metastasis and improve survival in breast cancer patCancer Conference on the use of beta - blockers to help reduce metastasis and improve survival in breast cancer patbreast cancer patcancer patients.

Statement from Breast Cancer Care on research into the use of beta - blockers for breast cancer paBreast Cancer Care on research into the use of beta - blockers for breast cancer paCancer Care on research into the use of beta - blockers for breast cancer pabreast cancer pacancer patients

However, other research has suggested that the estrogen - like effects of isoflavones may reduce the effectiveness of endocrine therapies used to treat breast cancer.

Invisible tattoos could replace the permanent dark ink tattoos used to ensure that breast cancer patients having radiotherapy are treated in exactly the same spot during each session, according to results from a pilot study to be presented at the National Cancer Research Institute (NCRI) Cancer Confecancer patients having radiotherapy are treated in exactly the same spot during each session, according to results from a pilot study to be presented at the National Cancer Research Institute (NCRI) Cancer ConfeCancer Research Institute (NCRI) Cancer ConfeCancer Conference.

These include the ability to bring new, innovative products to the market; progress in oncology, such as the approval of Genentech's drug Avastin for breast cancer and advances in the use of gene therapy, despite some setbacks; continuing progress in research on stem cells; the emergence of treatments for previously untreated diseases; and solutions for food and fuel shortages, such as biocrops and biofuels.

Its research includes a cluster of related interdisciplinary projects that examine disparities in breast cancer mortality between African - American and Caucasian women using animal models, molecular characterization of tumors, and behavioral research focused on social - environmental factors.

Researchers at the Kaiser Permanente Center for Health Research in Portland, Ore., concluded there is definitely a link between breast cancer and the use of menopausal hormone therapy, particularly estrogen - progestin treatment combinations.

The research team first used the blood of healthy individuals, spiking some of the blood with living breast cancer cells to see if the NanoFlares could detect them.

The audience will learn about the current state of breast cancer research, how data generated by NGS gene panels target variants of interest and have been developed and used in routine laboratory research, and the broader issues of breast cancer education, awareness, and community services.

Gerry Potter and Ray McCague of the Institute of Cancer Research in Surrey based their design strategy on tamoxifen, a drug widely used for treating breast cCancer Research in Surrey based their design strategy on tamoxifen, a drug widely used for treating breast cancercancer.

Eran Andrechek, a physiology professor in the College of Human Medicine at Michigan State University, has discovered that many of the various models used in breast cancer research can replicate several characteristics of the human disease, especially at the gene level.

Human breast tumors transplanted into mice are excellent models of metastatic cancer and are providing insights into how to attack breast cancers that no longer respond to the drugs used to treat them, according to research from Washington University School of Medicine in St. Louis.

The panel also called for «aggressive research» on using RU486 and other drugs in the antiprogrestin class as contraceptives and as treat - ment for endometriosis, uter - ine fibroids, advanced breast cancer and meningioma brain tumours.

The research, using cells from the Breast Cancer Now Tissue Bank and due to be published in Nature Communications, also shows that the epigenetic changes are inherited as long as the cell divides, and that the team's manipulations permanently and negatively affected the biology of a normal breast cell from a healthy indivBreast Cancer Now Tissue Bank and due to be published in Nature Communications, also shows that the epigenetic changes are inherited as long as the cell divides, and that the team's manipulations permanently and negatively affected the biology of a normal breast cell from a healthy indivbreast cell from a healthy individual.

The quest to improve survival of children with a high - risk brain tumor has led St. Jude Children's Research Hospital investigators to two drugs already used to treat adults with breast, pancreatic, lung and other cancers.

While highlighting the need for further research, the researchers hope their findings will encourage more plastic surgeons to use lipofilling to provide the best possible results of breast reconstruction for their patients undergoing breast cancer surgery.

A research team, led by Chao Cheng, Ph.D., Assistant Professor in the Department of Genetics at The Geisel School of Medicine at Dartmouth, used gene expression data from breast cancer patients to computationally infer the presence of different types of immune cells.

New research by scientists at the Pennsylvania Cancer and Regenerative Medicine Research Center, a division of the Baruch S. Blumberg Institute, shows that medicines currently used in HIV treatment may help to target chemotherapy for breastresearch by scientists at the Pennsylvania Cancer and Regenerative Medicine Research Center, a division of the Baruch S. Blumberg Institute, shows that medicines currently used in HIV treatment may help to target chemotherapy for breast cCancer and Regenerative Medicine Research Center, a division of the Baruch S. Blumberg Institute, shows that medicines currently used in HIV treatment may help to target chemotherapy for breastResearch Center, a division of the Baruch S. Blumberg Institute, shows that medicines currently used in HIV treatment may help to target chemotherapy for breast cancercancer.

Research by the Baruch S. Blumberg Institute's Pennsylvania Cancer and Regenerative Medicine Research Center suggests that the use of HIV drugs can allow for lower doses of chemotherapy in treating breast cancer, reducing side eCancer and Regenerative Medicine Research Center suggests that the use of HIV drugs can allow for lower doses of chemotherapy in treating breast cancer, reducing side ecancer, reducing side effects

«Many of these genes have been relatively undocumented to date and we now hope further research will untangle their exact role in breast cancer risk, and how we could use them to stop more women developing the disease.»

Rieger conducted her research in zebrafish exposed to paclitaxel, a chemotherapeutic agent used for ovarian, breast, lung, pancreatic and other cancers.

The remaining 75 percent remains with the foundation's San Diego affiliate where it will also be used to fund breast cancer research — much as this year's award to Scripps Research is being paid with money raised in pasresearch — much as this year's award to Scripps Research is being paid with money raised in pasResearch is being paid with money raised in past races.

SEATTLE, Feb. 05, 2018 (GLOBE NEWSWIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the publication of a landmark study in which Danish researchers used the Prosigna ® Breast Cancer Assay risk of recurrence (ROR) score to accurately predict rates of 10 - year distant recurrence (DR) of cancer in a comprehensive and population - based cohort including all postmenopausal women in Denmark with early - stage hormone receptor (HR)- positive, Her - 2 negative breast cancer who received 5 years of adjuvant endocrine therapy according to nationwide guidelines between 2000 andBreast Cancer Assay risk of recurrence (ROR) score to accurately predict rates of 10 - year distant recurrence (DR) of cancer in a comprehensive and population - based cohort including all postmenopausal women in Denmark with early - stage hormone receptor (HR)- positive, Her - 2 negative breast cancer who received 5 years of adjuvant endocrine therapy according to nationwide guidelines between 2000 andCancer Assay risk of recurrence (ROR) score to accurately predict rates of 10 - year distant recurrence (DR) of cancer in a comprehensive and population - based cohort including all postmenopausal women in Denmark with early - stage hormone receptor (HR)- positive, Her - 2 negative breast cancer who received 5 years of adjuvant endocrine therapy according to nationwide guidelines between 2000 andcancer in a comprehensive and population - based cohort including all postmenopausal women in Denmark with early - stage hormone receptor (HR)- positive, Her - 2 negative breast cancer who received 5 years of adjuvant endocrine therapy according to nationwide guidelines between 2000 andbreast cancer who received 5 years of adjuvant endocrine therapy according to nationwide guidelines between 2000 andcancer who received 5 years of adjuvant endocrine therapy according to nationwide guidelines between 2000 and 2003.

Dr. Jos Jonkers» research group studies the genetic basis of human breast cancer, using advanced mouse models for p53 - induced breast cancer, BRCA1 - and BRCA2 - associated hereditary breast cancer, and E-cadherin mutated invasive lobular carcinoma.

Our goal is to reach out to patients with metastatic breast cancer throughout the USA and Canada in order to study their cancer using cutting - edge genomic and molecular research studies performed at the Broad Institute by allowing patients to participate in these studies regardless of where they live.

Research led at the Yale School of Public Health have found that the majority of published papers analyzing the cost - effectiveness of a widely used test for breast cancer used a study design that can increase bias.

«With further research, we could potentially use these findings to change how we look at breast cancer imaging.»

«Our study contributes to improved reproducibility within research using biologics (antibodies), and clarifies earlier controversies within the field of estrogen and breast cancer, thus helping the field forward.

A major focus of their current cancer research is using animal, cell - based, molecular, and biophysical approaches to investigate the role of HIF - 1 in vascular and lymphatic metastasis of human breast cancer.

News 12 New Jersey, NewJersey.News12.com — June 15, 2017 Researcher Dr. Adana Llanos of Rutgers Cancer Institute of New Jersey and Rutgers School of Public Health discusses results from recent research that finds an association between breast cancer risk and use of some hair proCancer Institute of New Jersey and Rutgers School of Public Health discusses results from recent research that finds an association between breast cancer risk and use of some hair procancer risk and use of some hair products.

Long - term use of aspirin is associated with lower risk of dying from various types of cancers, including colorectal, lung, breast and prostate cancer, according to a study presented at the 2017 American Association for Cancer Research annual mecancer, according to a study presented at the 2017 American Association for Cancer Research annual meCancer Research annual meeting.

WPIX TV Channel 11, PIX11.com — June 15, 2017 Researcher Dr. Adana Llanos of Rutgers Cancer Institute of New Jersey and Rutgers School of Public Health discusses results from recent research that finds an association between breast cancer risk and use of some hair proCancer Institute of New Jersey and Rutgers School of Public Health discusses results from recent research that finds an association between breast cancer risk and use of some hair procancer risk and use of some hair products.

A comprehensive, collaborative research project is looking for protein biomarkers that can be used for early breast cancer detection with blood tests.

Last month, a new research study of 418 women (ages 20 to 85) examined their self - reported history of use of underarm cosmetic products and health status, in order to unveil a bit more about the link between antiperspirants and breast cancer.

A promising avenue of clinical research in breast cancer is the use of immune checkpoint inhibitors.

Using expertise in genomics and cell biology, Dr. Pillai is looking forward to expanding his research in the field of Tumor Immunology, with focus on Breast Cancer.

Where the money goes: Gateway's Breast Cancer Charity funds research only, so no money is used for education, outreach, or awareness programs.

This has been seen in various studies, including one large research project called «the Million Woman» study and the nurses health study, which showed a connection to breast cancer and also an increased risk of heart disease and stroke in women using hormone replacement therapy.

Second, tamoxifen — one of the most commonly prescribed breast cancer drugs (its also used preventively by some high - risk women)-- may have heart - protective effects for breast cancer patients and survivors, according to some research.

And the latest research suggests that this powerful duo could be a promising therapy for treating breast cancer cells, when used along with standard anti-hormonal therapy.

New research finds evidence of a link between use of certain hair products, such as dyes and relaxers, and raised risk of breast cancer in women.

Thursday's Multivitamin Supplements & Breast Cancer highlighted new research suggesting that multivitamin use may significantly increase the risk of breast (and prostate) cancer, while Friday's video, Relieving Yourself of Excess Estrogen, offered a natural strategy to reduce one'sBreast Cancer highlighted new research suggesting that multivitamin use may significantly increase the risk of breast (and prostate) cancer, while Friday's video, Relieving Yourself of Excess Estrogen, offered a natural strategy to reduce one'sCancer highlighted new research suggesting that multivitamin use may significantly increase the risk of breast (and prostate) cancer, while Friday's video, Relieving Yourself of Excess Estrogen, offered a natural strategy to reduce one'sbreast (and prostate) cancer, while Friday's video, Relieving Yourself of Excess Estrogen, offered a natural strategy to reduce one'scancer, while Friday's video, Relieving Yourself of Excess Estrogen, offered a natural strategy to reduce one's risk.

The Complete Natural Medicine Guide to Breast Cancer uses the most recent research studies and clinical evidence to explain the causes of breast cancer and techniques for its preveBreast Cancer uses the most recent research studies and clinical evidence to explain the causes of breast cancer and techniques for its preveCancer uses the most recent research studies and clinical evidence to explain the causes of breast cancer and techniques for its prevebreast cancer and techniques for its prevecancer and techniques for its prevention.

Guidelines for the appropriate use of herbs in human preliminary research see promise in the use of dandelion as an anti-cancer agent for both breast and prostate cancer.

It's Official - Less Synthetic HRT = Less Breast Cancer As the use of synthetic HRT has dropped, breast cancer rates have dropped, according to research published in the New England Journal of MedBreast Cancer As the use of synthetic HRT has dropped, breast cancer rates have dropped, according to research published in the New England Journal of MedCancer As the use of synthetic HRT has dropped, breast cancer rates have dropped, according to research published in the New England Journal of Medbreast cancer rates have dropped, according to research published in the New England Journal of Medcancer rates have dropped, according to research published in the New England Journal of Medicine.

Recent research suggests that statins (used to lower cholesterol), can improve progression - free survival in women with inflammatory breast cancer.

The world could always use more heroes, both in - game and out — which is why Overwatch has partnered with the Breast Cancer Research Foundation to work toward a cure for breast cBreast Cancer Research Foundation to work toward a cure for breast cCancer Research Foundation to work toward a cure for breast cbreast cancercancer.

These genetic tests, which grew out of federal funding for University of Utah research, can detect mutations that speak to much higher risks of breast cancer, which can be used, in turn, to take steps that significantly reduce those risks for women.